Abstract:Cadmium (Cd) is a well-known environmental pollutant with high toxicity. Despite a variety of studies have demonstrated that Cd exposure induces multiple organ damages in humans, there is still a lack of knowledge of Cd induced skeletal muscle impairment. Exercise is a non-invasive, effective intervention to improve human health and combat diseases. In this study, we aimed to evaluate the toxic effects of Cd exposure on skeletal muscle function and explore the possibility of exercise for attenuating skeletal muscle toxicity of chronic Cd exposure. C57BL/6J mice were exposed to Cd via drinking water containing CdCl2 10 mg/dL for 8 weeks while a moderate exercise was daily induced by a motorized treadmill to mice. It was found that Cd exposure significantly reduced the ratio of gastrocnemius and body weight, decreased mouse exercise capacity, weakened muscle strength, promoted lipid accumulation and up-regulated pro-apoptotic genes in the skeletal muscle. Non-targeted lipidomics analysis indicated that Cd exposure disturbed lipid metabolism, altered lipid signatures and elevated pro-inflammatory lipid species in the skeletal muscle. Moreover, Cd exposure evoked an intense inflammatory response in the skeletal muscle by up-regulating pro-inflammatory cytokine production such as Eotaxin (CCL11), TNF-α, IL-1β, IL-6, RANTES (CCL5) and so on. Notably, treadmill exercise effectively protected against Cd induced skeletal muscle impairment indicated by the effects of inhibiting lipid metabolism disturbance, suppressing pro-inflammatory cytokine production and preserving skeletal muscle function. These results demonstrated that environment relevant Cd exposure impairs skeletal muscle function and exercise effectively antagonizes the Cd toxicity in the skeletal muscle and preserves skeletal muscle function. This study provided the novel evidence for unraveling Cd toxicity on the skeletal muscle function and highlighted the possibility of considering exercise as a countermeasure for Cd induced skeletal muscle impairment at population level.

Ca2+/CaM/CaMK signaling is involved in cadmium-induced osteoclast differentiation

Cadmium induces differentiation of RAW264.7 cells into osteoclasts in the presence of RANKL

Cadmium Stimulates the Osteoclastic Differentiation of Raw264.7 Cells in Presence of Osteoblasts

Cadmium accelerates autophagy of osteocytes by inhibiting the PI3K/AKT/mTOR signaling pathway

Activation of NLRP3 signaling contributes to cadmium-induced bone defects, associated with autophagic flux obstruction

Low-dose cadmium exposure acts on rat mesenchymal stem cells via RANKL/OPG and downregulate osteogenic differentiation genes

Effect of long-term, low-dose exposure of cadmium on the formation of osteoclasts in rats

Low Levels of Cadmium Exposure Affect Bone by Inhibiting Lgr4 Expression in Osteoblasts and Osteoclasts.

Effects of cadmium on osteoblasts and osteoclasts in vitro.

Environmental level of cadmium exposure stimulates osteoclasts formation in male rats

Cadmium Modulates Hematopoietic Stem and Progenitor Cells and Skews Toward Myelopoiesis in Mice.

TGF-β-activated kinase 1 (TAK1) mediates cadmium-induced autophagy in osteoblasts via the AMPK / mTORC1 / ULK1 pathway

Calcium Signaling Involvement in Cadmium-Induced Astrocyte Cytotoxicity and Cell Death Through Activation of MAPK and PI3K/Akt Signaling Pathways

MircoRNA-143-3p regulating ARL6 is involved in the cadmium-induced inhibition of osteogenic differentiation in human bone marrow mesenchymal stem cells

Prolonged Cadmium Exposure and Osteoclastogenesis: A Mechanistic Mouse and in Vitro Study

Cadmium Exposure Impairs Skeletal Muscle Function by Altering Lipid Signature and Inducing Inflammation in C57BL/6J Mice

Association of environmental cadmium exposure and bone remodeling in women over 50 years of age

Effects of Cadmium on Proliferation,apoptosis,differentiation and Mineralization in Osteoblast in Vitro

Metabolic signatures for safety assessment of low-level cadmium exposure on human osteoblast-like cells

From the Cover: Autophagy Induction Contributes to Cadmium Toxicity in Mesenchymal Stem Cells via AMPK/FOXO3a/BECN1 Signaling

Emodin Suppresses Cadmium-Induced Osteoporosis by Inhibiting Osteoclast Formation.